Pharmacokinetics of ML3403 ({4-[5-(4-Fluorophenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenylethyl)-amine), a 4-Pyridinylimidazole-Type p38 Mitogen-Activated Protein Kinase Inhibitor

2007 ◽  
Vol 35 (6) ◽  
pp. 875-883 ◽  
Author(s):  
Bernd Kammerer ◽  
Holger Scheible ◽  
Wolfgang Albrecht ◽  
Christoph H. Gleiter ◽  
Stefan Laufer
Keyword(s):  
Protein Kinase ◽  
Kinase Inhibitor ◽  
Protein Kinase Inhibitor ◽  
Mitogen Activated Protein Kinase ◽  
Mitogen Activated Protein

scholarly journals The p38 Mitogen-Activated Protein Kinase Inhibitor SB203580 Reduces Glucose Turnover by the Glucose Transporter-4 of 3T3-L1 Adipocytes in the Insulin-Stimulated State

Endocrinology ◽  
2005 ◽  
Vol 146 (4) ◽  
pp. 1818-1824 ◽  
Author(s):  
Merlijn Bazuine ◽  
Françoise Carlotti ◽  
Martijn J. W. E. Rabelink ◽  
Jort Vellinga ◽  
Rob C. Hoeben ◽  
...  
Keyword(s):  
Protein Kinase ◽  
Glucose Transporter ◽  
Kinase Inhibitor ◽  
Protein Kinase Inhibitor ◽  
Mitogen Activated Protein Kinase ◽  
Glucose Turnover ◽  
Glucose Transporter 4 ◽  
Mitogen Activated Protein

FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine model

2006 ◽  
Vol 72 (1-2) ◽  
pp. 85-93 ◽  
Author(s):  
Osamu Yoshino ◽  
Yutaka Osuga ◽  
Kaori Koga ◽  
Yasushi Hirota ◽  
Tetsuya Hirata ◽  
...  
Keyword(s):  
Protein Kinase ◽  
Murine Model ◽  
Kinase Inhibitor ◽  
Protein Kinase Inhibitor ◽  
Mitogen Activated Protein Kinase ◽  
Mitogen Activated Protein
Sign in / Sign up

Export Citation Format

Share Document